These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3124534)

  • 21. A glimmer of hope for prevention.
    Mani MK
    Natl Med J India; 2010; 23(2):109-10. PubMed ID: 20925214
    [No Abstract]   [Full Text] [Related]  

  • 22. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing diabetic nephropathy: the role of primary care.
    Aiello JH
    Nurse Pract; 1998 Feb; 23(2):12-3, 17-8, 23-4 passim; quiz 32-3. PubMed ID: 9513216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic nephropathy. The internist's role.
    Rocher L
    Arch Intern Med; 1990 Jan; 150(1):26-8. PubMed ID: 2297295
    [No Abstract]   [Full Text] [Related]  

  • 28. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.
    Clark WF; Churchill DN; Forwell L; Macdonald G; Foster S
    CMAJ; 2000 Jan; 162(2):195-8. PubMed ID: 10674051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
    Remuzzi G; Macia M; Ruggenenti P
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic nephropathy. Is a pound of treatment better than an ounce of prevention?
    Goldstein DE
    Mo Med; 1994 Jun; 91(6):291. PubMed ID: 8052219
    [No Abstract]   [Full Text] [Related]  

  • 31. Beneficial effects of soy protein consumption for renal function.
    Anderson JW
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():324-8. PubMed ID: 18296369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The feasibility and current limits in the prevention of diabetic nephropathy].
    Savazzi GM; Cella MT; Mazzi A
    Ann Ital Med Int; 1996; 11(1):39-45. PubMed ID: 8645529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 34. [Renal complications of diabetes].
    Tielemans C
    Rev Med Brux; 1995; 16(4):258-61. PubMed ID: 7481238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic nephropathy. Is end-stage renal disease inevitable?
    Bogusky RT
    Postgrad Med; 1983 Oct; 74(4):339-49. PubMed ID: 6353391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-term prevention of diabetic nephropathy in a patient with type 1 diabetes after simultaneous pancreas and kidney transplantation.
    Nyumura I; Honda K; Babazono T; Taneda S; Horita S; Teraoka S; Yamaguchi Y; Iwamoto Y; Oda H
    Clin Transplant; 2009 Aug; 23 Suppl 20():54-7. PubMed ID: 19594598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
    Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
    J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diabetic nephropathy: preventive role of therapy].
    Brunetti P; Bueti A
    Minerva Urol Nefrol; 1984; 36(4 Suppl):25-30. PubMed ID: 6398921
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelets, antiplatelet therapy, and diabetic nephropathy.
    Nath KA
    Mayo Clin Proc; 1988 Jan; 63(1):80-5. PubMed ID: 3275846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.